Analysis demonstrates different impairment substrates in multiple sclerosis patients with adult- and late-onset, suggesting tailored approaches are needed.
Substrates contributing to SDMT impairment differ between these two distinct cohorts, being primarily driven by network dysfunction in AOMS and neurodegenerative processes in LOMS.
No takes yet. Share an insight, caveat, or question.
Wenger et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: